1,951 Shares in Agilent Technologies, Inc. $A Bought by Allegiance Financial Group Advisory Services LLC

Allegiance Financial Group Advisory Services LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 1,951 shares of the medical research company’s stock, valued at approximately $230,000.

Several other hedge funds also recently bought and sold shares of A. Brighton Jones LLC boosted its holdings in shares of Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. Merit Financial Group LLC boosted its holdings in shares of Agilent Technologies by 56.3% during the 1st quarter. Merit Financial Group LLC now owns 4,348 shares of the medical research company’s stock valued at $509,000 after purchasing an additional 1,567 shares during the last quarter. Capital Investment Advisors LLC boosted its holdings in shares of Agilent Technologies by 42.3% during the 1st quarter. Capital Investment Advisors LLC now owns 2,809 shares of the medical research company’s stock valued at $329,000 after purchasing an additional 835 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Agilent Technologies by 34.6% during the 1st quarter. GAMMA Investing LLC now owns 5,362 shares of the medical research company’s stock valued at $627,000 after purchasing an additional 1,379 shares during the last quarter. Finally, Fiduciary Financial Group LLC bought a new position in shares of Agilent Technologies during the 1st quarter valued at about $318,000.

Agilent Technologies Stock Up 1.6%

Shares of NYSE A opened at $140.81 on Thursday. The firm’s 50-day moving average price is $124.07 and its 200-day moving average price is $116.81. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $39.92 billion, a price-to-earnings ratio of 33.05, a P/E/G ratio of 4.52 and a beta of 1.26. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the company posted $1.32 EPS. The firm’s revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is 23.24%.

Analyst Upgrades and Downgrades

Several research firms have commented on A. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a report on Wednesday. They set a “buy” rating and a $165.00 price objective for the company. Evercore ISI increased their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a report on Tuesday. Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. Finally, Barclays upped their target price on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research report on Thursday, October 2nd. Eight analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $147.92.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.